SpringWorks Therapeutics Stock Forecast - Polynomial Regression
| SWTXDelisted Stock | USD 46.99 0.00 0.00% |
The Polynomial Regression forecasted value of SpringWorks Therapeutics on the next trading day is expected to be 46.52 with a mean absolute deviation of 1.12 and the sum of the absolute errors of 68.07. SpringWorks Stock Forecast is based on your current time horizon.
At this time the value of rsi of SpringWorks Therapeutics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using SpringWorks Therapeutics hype-based prediction, you can estimate the value of SpringWorks Therapeutics from the perspective of SpringWorks Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of SpringWorks Therapeutics on the next trading day is expected to be 46.52 with a mean absolute deviation of 1.12 and the sum of the absolute errors of 68.07. SpringWorks Therapeutics after-hype prediction price | USD 46.99 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
SpringWorks |
SpringWorks Therapeutics Additional Predictive Modules
Most predictive techniques to examine SpringWorks price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SpringWorks using various technical indicators. When you analyze SpringWorks charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
SpringWorks Therapeutics Polynomial Regression Price Forecast For the 24th of January
Given 90 days horizon, the Polynomial Regression forecasted value of SpringWorks Therapeutics on the next trading day is expected to be 46.52 with a mean absolute deviation of 1.12, mean absolute percentage error of 3.08, and the sum of the absolute errors of 68.07.Please note that although there have been many attempts to predict SpringWorks Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that SpringWorks Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
SpringWorks Therapeutics Stock Forecast Pattern
| Backtest SpringWorks Therapeutics | SpringWorks Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of SpringWorks Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent SpringWorks Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.237 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.1159 |
| MAPE | Mean absolute percentage error | 0.0269 |
| SAE | Sum of the absolute errors | 68.0726 |
Predictive Modules for SpringWorks Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SpringWorks Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SpringWorks Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
SpringWorks Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of SpringWorks Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in SpringWorks Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of SpringWorks Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
SpringWorks Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting SpringWorks Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on SpringWorks Therapeutics' historical news coverage. SpringWorks Therapeutics' after-hype downside and upside margins for the prediction period are 46.99 and 46.99, respectively. We have considered SpringWorks Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
SpringWorks Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of SpringWorks Therapeutics is based on 3 months time horizon.
SpringWorks Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as SpringWorks Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SpringWorks Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with SpringWorks Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 11 Events / Month | 1 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
46.99 | 46.99 | 0.00 |
|
SpringWorks Therapeutics Hype Timeline
SpringWorks Therapeutics is at this time traded for 46.99. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. SpringWorks is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on SpringWorks Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 46.99. About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.41. SpringWorks Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.SpringWorks Therapeutics Related Hype Analysis
Having access to credible news sources related to SpringWorks Therapeutics' direct competition is more important than ever and may enhance your ability to predict SpringWorks Therapeutics' future price movements. Getting to know how SpringWorks Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how SpringWorks Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CBAY | Cymabay Therapeu | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MOR | MorphoSys AG ADR | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MORF | Morphic Holding | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RYZB | RayzeBio Common Stock | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KDNY | Chinook Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MRTX | Mirati Ther | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MYOV | Myovant Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OPT | Opthea | (0.03) | 4 per month | 6.72 | 0.0008 | 8.61 | (7.55) | 44.59 | |
| ONEM | 1Life Healthcare | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PRVB | Provention Bio | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SpringWorks Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SpringWorks Therapeutics stock to make a market-neutral strategy. Peer analysis of SpringWorks Therapeutics could also be used in its relative valuation, which is a method of valuing SpringWorks Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
SpringWorks Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how SpringWorks Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SpringWorks Therapeutics shares will generate the highest return on investment. By undertsting and applying SpringWorks Therapeutics stock market strength indicators, traders can identify SpringWorks Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 6.0E-4 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 47.0 | |||
| Day Typical Price | 46.99 | |||
| Market Facilitation Index | 0.03 | |||
| Price Action Indicator | (0.01) |
SpringWorks Therapeutics Risk Indicators
The analysis of SpringWorks Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in SpringWorks Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting springworks stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.57 | |||
| Semi Deviation | 2.82 | |||
| Standard Deviation | 3.24 | |||
| Variance | 10.48 | |||
| Downside Variance | 13.62 | |||
| Semi Variance | 7.97 | |||
| Expected Short fall | (1.50) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for SpringWorks Therapeutics
The number of cover stories for SpringWorks Therapeutics depends on current market conditions and SpringWorks Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that SpringWorks Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about SpringWorks Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
SpringWorks Therapeutics Short Properties
SpringWorks Therapeutics' future price predictability will typically decrease when SpringWorks Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of SpringWorks Therapeutics often depends not only on the future outlook of the potential SpringWorks Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SpringWorks Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74.1 M | |
| Cash And Short Term Investments | 308 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in SpringWorks Stock
If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world |